Recent patents on biotechnology最新文献

{"title":"Assessment of Blockchain Technology in the Improvement of Supply Chain Management in the Pharmaceutical Industry.","authors":"Dinesh Kumar, Rajni Tanwar, Debarshi Kar Mahapatra, Nisham Lohan, Geetanjali Dahiya, Divya Jain","doi":"10.2174/0118722083347810250711232759","DOIUrl":"https://doi.org/10.2174/0118722083347810250711232759","url":null,"abstract":"<p><p>Blockchain technology has drawn a lot of interest in the healthcare industry in recent years. Efficient data management is crucial for pharmacies. Blockchain technology is a novel technology that has the potential to make many pharmaceutical processes safer and more transparent. In 2013, the US Congress created the Drug Supply Chain Security Act [DSCSA] to prevent the distribution of stolen, contaminated, or counterfeit drugs. Blockchain technology serves as an answer to this problem as it enables the tracking and tracing the product from manufacturer to patient through an electronic, immutable, digitized tracking record of all steps from inventory to consumer in the drug supply chain. To ensure the safety of a peer-to-peer network of transactions, blockchain technology employs cryptographic methods to create a distributed ledger that is not centralized. Incorporating it into a product ensures its safety and marketability. Blockchain technology offers solutions to enhance the validity, reliability, and efficiency of medication manufacturing by facilitating easy compliance with legislation. Additionally, it offers an opportunity to address a major problem: the proliferation of counterfeit drugs that enter the system and ultimately reach consumers. The pharmaceutical industry's deficient supply chain management results in counterfeit and fake drug entering the supply chain and negatively affecting patients' health, leading to serious complications or even death. Supply chain management may benefit from blockchain technology's transparency and immutability at every step of the process, which increases confidence, security, traceability, and transparency. Blockchain technology, designed to manage electronic data, holds promise for enhancing clarity. Every user of a computer network has access to the same immutable record of transactions known as a blockchain.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144744550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recent Patents of Stent Grafts for Intravascular Aortic Repair.","authors":"Yiwen Wang, Yuxin Zhang","doi":"10.2174/0118722083355380250716073539","DOIUrl":"https://doi.org/10.2174/0118722083355380250716073539","url":null,"abstract":"<p><strong>Introduction: </strong>Endovascular aortic repair involves the placement of stents through minimally invasive methods to seal rupture sites near the aortic inflow tract, thereby preventing blood entry into the false lumen and promoting thrombosis, which reduces the risk of aortic rupture. Endovascular stents typically consist of a metal framework and a flexible membrane graft designed to reopen obstructed aortic segments and maintain blood flow through the true lumen. Consequently, stents are widely used to treat aortic expansion diseases and aortic occlusive stenosis. However, traditional stents have limitations in terms of adaptability to complex anatomical structures, long-term durability, biomechanical stability, and reliance on radial support force for fixation, lacking active fixation mechanisms. These shortcomings remain the primary causes of postoperative complications, significantly impacting the quality of life for patients with aortic dissection.</p><p><strong>Methods: </strong>The research status of the endovascular stent was discussed in depth, and the main factors for the optimal design of the stent (geometry, pattern configuration, additional fixtures, and optimization methods) were analyzed and summarized according to the complications targeted by the repair device.</p><p><strong>Results: </strong>The composition structure, working principle, and development status of the stent grafts under review are elaborated in detail. Stent grafts attempt to alleviate postoperative complications through three approaches: enhancing the flexibility of the stent framework, improving the fit between the vessel wall and the stent, and reducing vascular injury. Blood flow guiding channels are established to alleviate the obstruction of branch blood flow. Additional self-anchoring devices are added to adapt to the dynamic remodeling of blood vessels.</p><p><strong>Discussion: </strong>The effects of various factors, including geometric parameters, structural design, and parameter optimization techniques, on the optimization of stent primary mechanical performance are discussed. The current research status of functional improvement methods for stents is also summarized.</p><p><strong>Conclusion: </strong>Refining the quantitative relationship between stent structural parameters and mechanical performance, as well as exploring the balance criteria between flexibility and radial support force, represent promising directions for future development. These objectives necessitate further in-depth analysis and research.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144708587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Technologies for Conservation of Horseshoe Crabs: A Patent Landscape Analysis.","authors":"Utpal Mallick, Sumit Biswas","doi":"10.2174/0118722083369051250708143745","DOIUrl":"https://doi.org/10.2174/0118722083369051250708143745","url":null,"abstract":"<p><p>The horseshoe crab, a Xiphosurid species with an ancient lineage that dates back 450 million years, has proven to be a precious asset to the pharmaceutical industry. The blood extracted from these creatures is an irreplaceable component in detecting bacterial endotoxins, crucially important in pharmaceutical and functional settings. Unfortunately, these living ancient organisms are threatened from multiple perspectives and are now considered endangered. While efforts to conserve these creatures are underway, exploring technologies for their conservation can help us understand the latest advancements in the field and shed light on areas that have not yet been targeted. This analytical report is the first of its kind in this domain and provides a comprehensive overview of the available patents associated with the conservation of horseshoe crabs. The analysis is based on an extensive dataset (413) that describes technology for conservation of these living fossils, with a focus on recombinant proteins that can be a viable alternative to the mass utilization of the horseshoe crabs for the extraction of limulus amoebocyte lysate. Other technological advances which advocate cell-free hemolymph production and the use of artificial baits to replace the traditional grassroot practices, procedures related to efficient breeding, growth, hatching and release from artificial culture systems can go a long way in the conservation of these living fossils. Transitioning to recombinant Factor C, a ban on horseshoe crab baits, diversity mapping through genetic markers and artificial breeding techniques are some of the measures that can be manifested at the policy level to enhance conservation efforts.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144650263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"From Potential to Reality: Unraveling the Factors Limiting the Use of Microalgae as Sustainable Blue Food Protein Sources - A Critical Review.","authors":"Luisa Chitolina Schetinger, Marcele Leal Nörnberg, Tatiele Casagrande do Nascimento, Leila Queiroz Zepka, Eduardo Jacob-Lopes","doi":"10.2174/0118722083358276250703100020","DOIUrl":"https://doi.org/10.2174/0118722083358276250703100020","url":null,"abstract":"<p><p>Microalgae are promising and sustainable sources of blue food proteins, offering high nutritional quality, environmental resilience, and the potential to meet the rising demand for alternative proteins. Despite these advantages, several challenges hinder their large-scale adoption, including production costs, regulatory barriers, protein extraction difficulties, and consumer perception. This review explores the key factors limiting the use of microalgae in the food industry, addressing economic and technological feasibility, regulatory aspects, and consumer acceptance. The analysis includes commonly used microalgae species, their nutritional profiles, and strategies for optimizing their incorporation into food products. Moreover, developing circular biorefineries and utilizing industrial wastewater for cultivation presents a viable solution to reduce costs and enhance sustainability. Additionally, advancements in protein extraction techniques, combined with technological innovations such as microencapsulation, may overcome sensory challenges, expanding consumer acceptance of microalgae-enriched products. Raising consumer awareness of the nutritional and environmental benefits of microalgae is also crucial for market adoption. Given the global need for sustainable food sources, microalgae represent a viable alternative but require scientific, regulatory, and strategic advancements to become a widely adopted solution in the alternative protein industry.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144637883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Effect of Biosurfactant Isolated from Actinobacteria on the bfp Gene Expression of Aeromonas hydrophila, Isolated from Children's Stool Samples.","authors":"Sina Ghobadi, Pegah Shakib, Ashkan Dirbaziyan, Mohsen Zargar","doi":"10.2174/0118722083366860250623142119","DOIUrl":"https://doi.org/10.2174/0118722083366860250623142119","url":null,"abstract":"<p><strong>Introduction: </strong>Aeromonas hydrophila, a rod-shaped, gram-negative bacterium, is frequently found in aquatic surroundings and additionally present in drinking water, sewage, and food sources. This microbe is gaining recognition as a potential threat to health, classifying it as an emerging pathogen. Biosurfactants are microbial-derived compounds that share hydrophilic and hydrophobic moieties that are surface active. This study aimed to investigate the effect of biosurfactant isolated from Actinobacteria on the expression of the bfp gene of A. hydrophila isolated from the stool samples of children referred to Hazrat Masoumeh Hospital in Qom, Iran, from May 2022 to March 2023.</p><p><strong>Materials and methods: </strong>Actinobacteria were isolated from soil samples of the desert areas of Qom province, Iran. Biochemical and molecular tests of 16S rRNA were used to identify Actinobacteria isolates. The produced biosurfactant was investigated by methods of hemolysis, oil droplet destruction, lipase production, oil expansion, emulsifying activity, and surface tension reduction measurement. The structure of biosurfactant was investigated by Fourier transform infrared spectroscopy (FTIR) analysis, and its effect on bfp gene expression was measured. Also, isolates of A. hydrophila were obtained from stool samples of children referred to Hazrat Masoumeh Hospital in Qom from May 2022 to March 2023. Then, the effect of a biosurfactant isolated from Actinobacteria on the bfp gene expression of A. hydrophila isolates was measured by RT-PCR.</p><p><strong>Results: </strong>Based on sequencing data, the Streptomyces genus with the ability to produce biosurfactant was isolated from the soil of the studied area, which could reduce the expression of the bfp gene after treatment with biosurfactant in clinical isolates of A. hydrophila.</p><p><strong>Conclusion: </strong>The findings of the present study show that the desert soils of Qom province are a potential area for finding actinobacterial isolates with the ability to produce biosurfactants and influence the expression of pathogenic genes of clinical isolates of A. hydrophila.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144609266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of Pharmacognostical and Anti-Ulcer Potential of Vernonia anthelmintica (L.) Willd Seed in Aspirin-Induced Ulcer Rats.","authors":"Nidhi Bisht, Divya Jain, Neeraj Bainsal, Chandan Sharma","doi":"10.2174/0118722083376311250526075839","DOIUrl":"https://doi.org/10.2174/0118722083376311250526075839","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Vernonia anthelmintica (L.) Willd., commonly known as Kalijiri, has been used for the treatment of different ailments, including stomach aches, skin diseases, asthma, and cough, and is popular as a powerful anthelmintic agent.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aims: &lt;/strong&gt;This study aimed to evaluate the pharmacognostical, physicochemical, and phytochemical parameters along with the in-vivo antiulcer activity of the seeds of Vernonia anthelmintica (L.) Willd.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The pharmacognostical evaluation included macroscopic and microscopic characterization of the seed and powder of Vernonia anthelmintica (L.) Willd. Physicochemical parameters, such as moisture content, ash values, and extractive values, were evaluated, and fluorescence analysis was carried out. Phytochemical screening, including total flavonoid content (TFC) and total phenolic content (TPC), was conducted, along with antioxidant analysis. The anti-ulcer activity of ethanolic extract of V. anthelmintica seeds was also evaluated using an aspirin-induced ulcer model by employing multiple biochemical and histopathological assessment parameters.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The morphological characteristics of V. anthelmintica seeds demonstrated that the seed was 0.8-1 cm in length and 0.1-0 in width, with a bitter taste, whereas microscopical findings revealed the presence of pericarp, endosperm, sclerenchymatous zone, parenchymatous zone, bundles of sclereids, seed coat, and prismatic crystals. Moisture content and ash values, including total ash, acid-insoluble ash, and water-soluble ash, were approximately 10.05%, 8.50%, 2.06%, and 4.35%, respectively. Extractive values of different solvents (petroleum ether, chloroform, benzene, ethanol, and water) were approximately 16.00%, 15.80%, 2.00%, 7.05%, and 1.06%, respectively. Moreover, fluorescence analysis revealed a characteristic brown colour. Preliminary phytochemical analysis showed the presence of phenolic, carbohydrates, proteins, flavonoids, saponins, diterpenes, steroids, and amino acids. The TFC and TPC revealed that the ethanolic extract contained more phenolic content, whereas the aqueous extract contained more flavonoids. The ethanolic extract exhibited 90% DPPH radical scavenging activity at a concentration of 100 μg/mL, while the aqueous extract showed 85.71% activity at the same concentration. In comparison, ascorbic acid demonstrated 94.32% scavenging activity at 40 μg/mL. The ethanolic extract of V. anthelmintica seeds at doses 200 and 400mg/kg showed a significant decrease in the ulcer index values, gastric volume, and total acidity levels, whereas an increase was observed in the SOD and GSH levels. The extract demonstrated a moderate effect on the levels of Hb and total protein when compared with the disease control group. The histopathological findings revealed the antiulcer potential of ethanolic extract of V. anthelmintica seeds at both doses.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/str","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144560996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Integrating Biosensors in Phytochemical Research: Challenges and Breakthroughs.","authors":"Hanuman Ram Choudhary, Dileep Kumar B, Sunil Kumar Kadiri, Deepak S Khobragade, Prashant Tiwari","doi":"10.2174/0118722083381223250612181959","DOIUrl":"https://doi.org/10.2174/0118722083381223250612181959","url":null,"abstract":"<p><p>Biosensors are devices that generate signals by interaction of biological elements and analytes, mainly based on their concentration. These are especially composed of enzymes or antibodies. They are associated with a physio-chemical transducer. Their rapid, simple, and real-time detection is of great importance in chemistry, analysis, and drug discovery and development. Phytoconstituents are biologically active compounds mainly synthesized by plants to support their growth and defend against various stresses. Medicinal plants and their products have a vast history of use in traditional medicine, but they are not reliable due to their narrow range and adverse and toxic effects. Moreover, they have vast therapeutic effects on humans, from antibiotics to anti-neoplastic agents. Hence, there is a need for an efficient method to detect and measure these phytoconstituents, and biosensors seem to be the solution. This article provides an overview of various biosensors that can be utilized to identify widely used phytoconstituents, also known as secondary metabolites, such as alkaloids, tannins, flavonoids, terpenoids, cardiac glycosides, and phenolic compounds. The article discusses different types of biosensors, including impedimetric immunosensors, Riboswitch-based biosensors, DNA biosensors, electrochemical biosensors, and others.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144542025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cognition, Diagnosis, and Treatment of Alzheimer's Disease: A Review.","authors":"Yuping Qin, Xiangxia Deng, Shuang Zhang","doi":"10.2174/0118722083358924250606173812","DOIUrl":"10.2174/0118722083358924250606173812","url":null,"abstract":"<p><p>As the global population ages, the health of older adults has become a growing concern. Alzheimer's disease (AD) is a common ailment affecting older adults, but the diagnosis and treatment of AD are difficult given our insufficient understanding of the disease. This review aims to provide reliable information for patients and their families by presenting a detailed overview of the pathogenic factors, diagnostic methods, and clinical manifestation of AD, as well as advances in drug and physical therapies. The information presented here should help provide a more comprehensive understanding of AD for patients and their families and encourage family- or self-screening based on clinical manifestations, thus improving early AD detection. In addition, the current treatment methods for AD are summarized. Although a gold-standard treatment for AD is yet to be developed, controlled-release therapies and medications that slow disease progression or improve cognitive function are available. The appropriate treatment method depends on the patient's diagnosis and the local medical level, and the effectiveness of the treatments may vary. Therefore, improving our understanding of AD and cognition-related symptoms in the public is necessary to improve early AD diagnoses. This review provides information that will facilitate self-screening for AD based on clinical manifestations, which can improve the early clinical diagnosis rate.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144333746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Preface.","authors":"Nikolaos E Labrou","doi":"10.2174/0118722083417806250605092351","DOIUrl":"https://doi.org/10.2174/0118722083417806250605092351","url":null,"abstract":"","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144286350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Optimized Protocol for Sorghum Regeneration: Enhancing Embryogenic Callus Formation from Immature Inflorescences.","authors":"Bangaru Naidu Thaddi","doi":"10.2174/0118722083362270250116101522","DOIUrl":"https://doi.org/10.2174/0118722083362270250116101522","url":null,"abstract":"<p><strong>Aim: </strong>This study aims to develop an efficient and reproducible in vitro protocol for high-frequency embryogenic callus induction and subsequent plant regeneration in multiple sorghum (Sorghum bicolor L. Moench) cultivars, thereby establishing a foundation for genetic transformation, mutation breeding, and other biotechnological applications aimed at enhancing sorghum crop improvement and productivity.</p><p><strong>Background: </strong>Sorghum (Sorghum bicolor (L.) Moench) is an important cereal crop known for its adaptability to harsh environments and nutritional value. Despite its significance, sorghum remains challenging for in vitro propagation due to difficulties in regenerating callus tissue, especially from monocotyledonous explants. Callus induction and regeneration protocols are crucial for genetic transformation, mutation breeding, and biotechnological applications in sorghum improvement.</p><p><strong>Objective: </strong>To establish an effective in vitro protocol for callus induction and subsequent plant regeneration using different sorghum cultivars, optimizing conditions for highfrequency embryogenic callus formation and plant regeneration.</p><p><strong>Methods: </strong>Six sorghum cultivars (IS 3477, IS 33095, IS 7155, IS 2898, IS 7005, and IS 1202) were selected. Immature inflorescence explants were cultured on a modified Murashige and Skoog's (MS) medium with 3% sucrose, 0.8% agar, and 2.0 mg/l 2,4-D for callus induction. After 14 days, embryogenic and non-embryogenic calli were distinguished. Regeneration media were optimized using embryogenic calli, with 1.5 mg/l 6- benzylaminopurine (BAP) for shoot development and 1 mg/l NAA (1-naphthaleneacetic acid) in a half-strength MS medium for root development.</p><p><strong>Results: </strong>Two distinct forms of calli were observed: a non-embryogenic light yellow callus and a white, granular embryogenic callus. Embryogenic callus induction frequency varied from 40% to 96% among the cultivars, with IS 3477 and IS 33095 exhibiting the highest frequencies (96% and 88%, respectively), while IS 1202 showed the lowest (40%). Regenerated shoots were successfully developed within 6-18 days and later transferred to a rooting medium, resulting in healthy plantlets. Transplanted plantlets showed normal growth and no morphological abnormalities in the field.</p><p><strong>Conclusion: </strong>This study provides a reliable protocol for efficient callus induction and plant regeneration in multiple sorghum cultivars. The optimized conditions can be utilized for genetic studies, crop improvement, and biotechnological applications, thus contributing to the advancement of sorghum breeding and biotechnology research.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144199927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}